Medindia

X

Chelation Therapy Saves Life of a 22-year-old Cardiac Patient in India

by Shirley Johanna on  May 23, 2015 at 12:51 PM Heart Disease News   - G J E 4
A 22-year-old man who developed chest pain was treated successfully with chelation therapy at Sibia Medical Center in Punjab, India.
Chelation Therapy Saves Life of a 22-year-old Cardiac Patient in India
Chelation Therapy Saves Life of a 22-year-old Cardiac Patient in India
Advertisement

Life was running fairly smoothly for Kamaljit Singh, a goldsmith, after he had two stents installed in his arteries. A sudden and major chest pain, however, compelled him to see a cardiac expert and he was told to undergo a heart bypass.

Advertisement
Worried about post-bypass surgery complications, Singh consulted several other health experts who suggested him to opt for Chelation therapy.

Chelation therapy is a chemical process in which a synthetic solution ethylenediaminetetraacetic acid is injected into the bloodstream to remove heavy metals and/or minerals from the body.

As part of the therapy at Sibia Medical Center, Singh underwent 30 treatment sessions that helped him regain normalcy in health.

According to the doctors, formation of blood clots, after stents are implanted in patients, lead to heart attacks and sudden death.

Cardiologists for long have pondered what action to take in such situations, and now Chelation therapy has proven to be the perfect solution.

A study showed cardiovascular patients treated with Chelation therapy had a lower rate of myocardial infarction and death, than those treated with medications, angioplasty or heart bypass.

"In addition to Chelation therapy, cardiovascular rehabilitation program should include aggressive lifestyle change for all heart patients with or without angioplasty, stents or bypass surgery," said S.S. Sibia, director of Institute of Preventive Heart Care and consultant at Sibia Medical Center.

As per the protocol of Chelation therapy, the dose adjustment is based on kidney function and other parameters, and is administered intravenously once or twice per week for 20-30 sessions.

"For maintenance, treatments are administered monthly because new platelets are formed approximately every 3.5 weeks. Monthly treatments provide continued platelet aggregation inhibition."

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All